Isozyme-specific abnormalities of PKC in thyroid cancer: Evidence for post-transcriptional changes in PKC epsilon

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 2150-2159

  Knauf, Jeffrey A ^a,b   Ward, Laura S ^a,b   Nikiforov, Yuri E ^a,b   Nikiforova, Marina ^a,b   Puxeddu, Efisio ^a,b   Medvedovic, Mario ^a,b   Liron, Tamar ^a,b   Mochly Rosen, Daria ^a,b   Fagin, James A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; ISOENZYME; PROTEIN KINASE C;

ARTICLE; ENZYME SPECIFICITY; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; THYROID ADENOMA; THYROID CANCER; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0036095447     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.8441     Document Type: Article

References (56)

1. The extended protein kinase C superfamily
2. The ε isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts
3. Overexpression of protein kinase C-Δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity
4. Antisense expression of protein kinase C α inhibits the growth and tumorigenicity of human glioblastoma cells
5. Protein kinase-C activation during thyrotropin-stimulated proliferation of rat FRTL-5 thyroid cells
6. Specific role for protein kinase C β in cell differentiation
7. A role for ζ protein kinase C in nerve growth factor-induced differentiation of PC12 cells
8. Ceramide-induced translocation of protein kinase C-8 and -ε to the cytosol. Implications in apoptosis
9. Protein kinase C isoenzymes: Divergence in signal transduction?
10. Biology of the protein kinase C family
11. Regulation of protein kinase C and role in cancer biology
12. Protein kinase C and skin tumor promotion
13. Multistage carcinogenesis in mouse skin
14. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro
15. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin
16. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts
17. Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytes
18. Transgenic mice overexpressing protein kinase C Δ in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate
19. Transgenic mice overexpressing protein kinase C ε in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion
20. Protein kinase C δ
21. Overexpression of protein kinase C ε is oncogenic in rat colonic epithelial cells
22. Evidence against a role of general protein kinase C down-regulation in skin tumor promotion
23. Transformation by a ras oncogene causes increased expression of protein kinase C-α and decreased expression of protein kinase C-ε
24. Expression of four protein kinase C isoforms in rat fibroblasts. Differential alterations in ras-, src-, and fos-transformed cells
25. Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids
26. Assessment of protein kinase C isozymes by enzyme immunoassay and overexpression of type II in thyroid adenocarcinoma
27. Immunohistochemical evidence for the overexpression of protein kinase C in proliferative diseases of human thyroid
28. The natural protein kinase C α mutant is present in human thyroid neoplasms
29. Mutual antagonistic interactions between the thyrotropin (adenosine 3′,5′-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles
30. Increased membrane-bound protein kinase C in porcine thyroid cells following TSH exposure
31. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
32. Two G protein oncogenes in human endocrine tumors
33. Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid
34. Invasive human pituitary tumors express a point-mutated α-protein kinase-C
35. Protein kinase C α and tumorigenesis of the endocrine gland
36. Ectopic expression of a mutant form of PKC α originally found in human tumors: Aberrant subcellular translocation and effects on growth control
37. From amplification to gene in thyroid cancer: A high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization
38. Involvement of protein kinase C ε (PKCε) in thyroid cell death: A truncated chimeric PKCε cloned from a thyroid cancer cell line protects thyroid cells from apoptosis
39. Functions of the MDM2 oncoprotein
40. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident
41. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
42. Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: Use of a targeted differential RNA display method to select for mRNA subsets
43. Sequence and expression of human protein kinase C-ε
44. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
45. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
46. A mutant protein kinase C that can transform fibroblasts
47. Analysis of the role of protein kinase C-α, -ε, and -ζ in T cell activation
48. Conventional PKC-α, novel PKC-ε and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts
49. Failure of wild-type or a mutant form of protein kinase C-α to transform fibroblasts
50. Activation of novel protein kinases C δ and C ε upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts
51. The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation
52. The SSCP phenomenon: Addition of HEPES buffer dramatically affects electrophoretic mobility
53. MDM2 - Master regulator of the p53 tumor suppressor protein
54. The MDM2 gene amplification database
55. Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features